CLS Group (CLS), a risk mitigation services provider to the global foreign exchange (FX) market, has had four new candidates elected to its Board of Directors, following an Annual General Meeting held back on 21 April, 2015, according to a CLS statement.
Peter Healey joins CLS’ Board of Directors, who currently serves as the Managing Director and Global COO, FX, Rates and Credit at UBS. Mr. Healey originally joined UBS Group AG back in 1994, having been responsible for a multitude of operations.
Ericka Leslie also joins the Board of Directors at CLS – she presently works as the Global Head of Regulatory Operations, Derivatives and Clearing Operations at Goldman Sachs. Ms. Leslie has been a mainstay at the lender Goldman Sachs since 1996, where she is tasked with the implementation of operational strategy and regulatory compliance.
Kohle Capital Strengthening Retail OfferingGo to article >>
In addition, Steven Lieblich is the third electoral entrant to the CLS Board of Directors – Mr. Lieblich serves as Morgan Stanley’s Co-Chief Information Officer of the bank’s Information Technology Division. A veteran of Morgan Stanley for nearly three decades, he also maintains an active role on the technology advisory committees of FINRA and Red Hat.
Lastly, Bruce MacLaren, the Senior Vice President, Group Risk Management – Credit at Royal Bank of Canada joins CLS’ Board of Directors. Mr. MacLaren has been involved with RBC since 1987, having held a number of senior level roles during his tenure.
According to CLS Chairman, Chairman Ken Harvey in a recent statement on the appointments, “I am delighted that Peter, Ericka, Steven and Bruce are joining the CLS Board. They will provide valuable counsel in critical areas including operations, technology and risk.”
“Their collective wisdom, drawn from years of financial industry experience, will help ensure CLS grows and seeks to identify new opportunities to mitigate risk and provide value for our members and the global FX market,” added CLS CEO David Puth in an accompanying statement.